Science|Business
Policy Analysis: Investment, Life Sciences, Policy
Published: 22 November 2012
The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate

Peter Winter

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue


Image: Bigstock
Advertisement